Vascular Solutions Stock Price, News & Analysis (NASDAQ:VASC)

Previous Close$56.00
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio81.16
Dividend YieldN/A
BetaN/A

About Vascular Solutions (NASDAQ:VASC)

Vascular Solutions logoVascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Receive VASC News and Ratings via Email

Sign-up to receive the latest news and ratings for VASC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Diagnostic & Testing Equipment
Sub-IndustryHealth Care Supplies
SectorHealthcare
SymbolNASDAQ:VASC
CUSIP92231M10
Phone+1-763-6564300

Debt

Debt-to-Equity RatioN/A
Current Ratio6.37%
Quick Ratio4.66%

Price-To-Earnings

Trailing P/E Ratio81.1594202898551
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS$0.69
Net IncomeN/A
Net Margins13.02%
Return on Equity15.78%
Return on Assets14.30%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Vascular Solutions (NASDAQ:VASC) Frequently Asked Questions

What is Vascular Solutions' stock symbol?

Vascular Solutions trades on the NASDAQ under the ticker symbol "VASC."

How were Vascular Solutions' earnings last quarter?

Vascular Solutions, Inc. (NASDAQ:VASC) announced its quarterly earnings data on Monday, July, 25th. The medical device company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.30 by $0.03. The medical device company had revenue of $41.20 million for the quarter, compared to analyst estimates of $41.40 million. Vascular Solutions had a return on equity of 15.78% and a net margin of 13.02%. The company's revenue was up 9.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.29 earnings per share. View Vascular Solutions' Earnings History.

Who are some of Vascular Solutions' key competitors?

How do I buy Vascular Solutions stock?

Shares of Vascular Solutions can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Vascular Solutions?

Vascular Solutions' mailing address is 6464 Sycamore Ct N, MAPLE GROVE, MN 55369-6032, United States. The medical device company can be reached via phone at +1-763-6564300.


MarketBeat Community Rating for Vascular Solutions (VASC)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  114 (Vote Underperform)
Total Votes:  270
MarketBeat's community ratings are surveys of what our community members think about Vascular Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Vascular Solutions (NASDAQ:VASC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AHoldHold
Consensus Rating Score: N/AN/A2.002.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/A$55.50
Price Target Upside: N/AN/AN/A0.89% downside

Vascular Solutions (NASDAQ:VASC) Consensus Price Target History

Price Target History for Vascular Solutions (NASDAQ:VASC)

Vascular Solutions (NASDAQ:VASC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/5/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
12/5/2016Canaccord GenuityDowngradeBuy -> HoldN/AView Rating Details
12/2/2016Feltl & Co.DowngradeBuy -> HoldN/AView Rating Details
12/2/2016Needham & Company LLCDowngradeBuy -> HoldN/AView Rating Details
7/12/2016SidotiDowngradeBuy -> Neutral$47.00N/AView Rating Details
(Data available from 2/18/2016 forward)

Earnings

Vascular Solutions (NASDAQ:VASC) Earnings History and Estimates Chart

Earnings by Quarter for Vascular Solutions (NASDAQ:VASC)

Vascular Solutions (NASDAQ VASC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2016Q3$0.30$0.31$41.60 million$41.77 millionViewListenView Earnings Details
7/25/2016Q216$0.30$0.33$41.40 million$41.20 millionViewListenView Earnings Details
4/25/2016Q116$0.23$0.25$38.37 million$39.00 millionViewListenView Earnings Details
1/21/2016Q415$0.27$0.33$37.53 million$38.09 millionViewListenView Earnings Details
10/20/2015Q315$0.25$0.27$36.41 million$37.00 millionViewListenView Earnings Details
7/21/2015Q215$0.25$0.29$35.59 million$37.60 millionViewListenView Earnings Details
4/21/2015Q115$0.18$0.21$33.38 million$34.61 millionViewN/AView Earnings Details
2/3/2015Q414$0.18$0.23$32.82 million$33.60 millionViewN/AView Earnings Details
10/21/2014Q314$0.20$0.15$31.10 million$31.90 millionViewListenView Earnings Details
7/22/2014Q214$0.18$0.20$30.43 million$30.70 millionViewN/AView Earnings Details
4/22/2014Q114$0.18$0.16$29.91 million$29.91 millionViewListenView Earnings Details
2/4/2014Q413$0.19$0.22$28.61 million$29.10 millionViewListenView Earnings Details
10/22/2013Q313$0.07$0.19$27.10 million$28.01 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.17$0.17$27.00 million$27.40 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.15$0.16$26.51 million$26.10 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.17$0.18$25.59 million$25.30 millionViewListenView Earnings Details
10/18/2012$0.15$0.16ViewN/AView Earnings Details
7/24/2012$0.13$0.15ViewN/AView Earnings Details
4/24/2012Q1 2012$0.11$0.12ViewN/AView Earnings Details
2/1/2012$0.13$0.13ViewN/AView Earnings Details
10/25/2011$0.17$0.10ViewN/AView Earnings Details
8/2/2011$0.12$0.13ViewN/AView Earnings Details
4/19/2011$0.10$0.10ViewN/AView Earnings Details
2/1/2011$0.12$0.12ViewN/AView Earnings Details
10/20/2010Q3 2010$0.10$0.09ViewN/AView Earnings Details
7/22/2010Q2 2010$0.10$0.09ViewN/AView Earnings Details
4/20/2010Q1 2010$0.08$0.08ViewN/AView Earnings Details
2/2/2010Q4 2009$0.10$0.10ViewN/AView Earnings Details
10/20/2009Q3 2009$0.09$0.09ViewN/AView Earnings Details
7/22/2009Q2 2009$0.07$0.09ViewN/AView Earnings Details
4/16/2009Q1 2009$0.06$0.06ViewN/AView Earnings Details
2/3/2009Q4 2008$0.12$0.09ViewN/AView Earnings Details
10/21/2008Q3 2008$0.06$0.11ViewN/AView Earnings Details
7/23/2008Q2 2008$0.04$0.03ViewN/AView Earnings Details
4/17/2008Q1 2008$0.04$0.02ViewN/AView Earnings Details
2/4/2008Q4 2007$0.02$0.03ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Vascular Solutions (NASDAQ:VASC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Vascular Solutions (NASDAQ:VASC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Vascular Solutions (NASDAQ VASC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 80.18%
Insider Trades by Quarter for Vascular Solutions (NASDAQ:VASC)
Insider Trades by Quarter for Vascular Solutions (NASDAQ:VASC)

Vascular Solutions (NASDAQ VASC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/22/2016Chad KuglerVPSell1,849$55.70$102,989.30View SEC Filing  
7/27/2016Howard RootCEOSell40,000$45.11$1,804,400.00347,840View SEC Filing  
7/27/2016William RutsteinVPSell10,011$46.26$463,108.86View SEC Filing  
5/24/2016Howard RootCEOSell34,418$39.05$1,344,022.90348,340View SEC Filing  
5/13/2016James HennenCFOSell11,785$38.12$449,244.2045,073View SEC Filing  
5/13/2016Martin J EmersonDirectorSell20,000$37.93$758,600.008,435View SEC Filing  
4/28/2016John L ErbDirectorSell10,000$35.58$355,800.0010,306View SEC Filing  
4/27/2016Howard RootCEOSell15,582$36.07$562,042.74351,340View SEC Filing  
4/27/2016Timothy SlaytonInsiderSell2,994$36.72$109,939.689,787View SEC Filing  
2/29/2016Charmaine SuttonVPSell14,325$30.13$431,612.2572,717View SEC Filing  
11/19/2015Jorge SaucedoDirectorSell7,715$33.45$258,066.7519,320View SEC Filing  
11/4/2015Richard NigonDirectorSell8,000$32.40$259,200.0057,008View SEC Filing  
11/2/2015Howard RootCEOSell18,062$32.03$578,525.86344,349View SEC Filing  
10/26/2015Carrie PowersVPSell5,412$32.77$177,351.2426,422View SEC Filing  
8/20/2015Jorge SaucedoDirectorSell2,285$38.00$86,830.0027,035View SEC Filing  
7/23/2015Timothy SlaytonInsiderSell1,587$38.61$61,274.07View SEC Filing  
5/28/2015Richard NigonDirectorSell6,000$32.68$196,080.00View SEC Filing  
5/4/2015Howard RootCEOSell25,000$32.62$815,500.00View SEC Filing  
4/27/2015Carrie PowersVPSell6,000$34.90$209,400.00View SEC Filing  
4/24/2015James HennenCFOSell4,792$35.66$170,882.72View SEC Filing  
2/10/2015William RutsteinVPSell10,814$26.91$291,004.74View SEC Filing  
2/5/2015James HennenCFOSell11,301$27.62$312,133.62View SEC Filing  
2/5/2015Jorge SaucedoDirectorSell10,000$27.36$273,600.00View SEC Filing  
11/26/2014Richard NigonDirectorBuy3,000$25.80$77,400.00View SEC Filing  
11/14/2014Richard W KrampDirectorBuy1,475$23.69$34,942.75View SEC Filing  
4/24/2014Timothy SlaytonInsiderSell1,390$23.15$32,178.509,265View SEC Filing  
2/27/2014James HennenCFOSell10,000$25.42$254,200.0050,151View SEC Filing  
2/25/2014Howard RootCEOSell50,000$24.74$1,237,000.00445,990View SEC Filing  
2/25/2014Richard NigonDirectorBuy1,000$25.66$25,660.0058,187View SEC Filing  
2/14/2014Howard RootCEOSell25,000$25.13$628,250.00445,990View SEC Filing  
2/11/2014Paul O'connellDirectorSell2,000$24.43$48,860.004,687View SEC Filing  
2/10/2014William RutsteinVPSell27,782$23.80$661,211.6038,425View SEC Filing  
10/28/2013James HennenCFOSell10,000$19.72$197,200.00View SEC Filing  
10/25/2013Jorge SaucedoDirectorSell2,000$19.70$39,400.00View SEC Filing  
7/26/2013Charmaine SuttonVPSell7,538$16.15$121,738.70View SEC Filing  
7/25/2013Howard RootCEOSell21,580$16.10$347,438.00View SEC Filing  
7/25/2013Howard RootCEOSell21,580$16.10$347,438.00View SEC Filing  
7/25/2013Paul O'connellDirectorSell30,000$16.11$483,300.00View SEC Filing  
5/17/2013Paul O'connellDirectorSell10,000$16.05$160,500.00View SEC Filing  
5/1/2013Richard NigonDirectorBuy3,000$15.57$46,710.00View SEC Filing  
11/26/2012Susan ChristianVPSell7,648$14.41$110,207.68View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Vascular Solutions (NASDAQ VASC) News Headlines

Source:
DateHeadline
Penumbra (PEN) Forms JV on Virtual Reality in Health SpacePenumbra (PEN) Forms JV on Virtual Reality in Health Space
www.zacks.com - January 5 at 4:01 PM
Toshiba Medical Expands Customer Education Solutions with Interactive Learning Tools Designed for the Modern LearnerToshiba Medical Expands Customer Education Solutions with Interactive Learning Tools Designed for the Modern Learner
www.businesswire.com - November 28 at 4:21 PM
Urinary Catheters Market is Worth US$ 15830 Million By 2022Urinary Catheters Market is Worth US$ 15830 Million By 2022
www.marketwatch.com - November 16 at 5:08 AM
Teleflex (TFX) Q3 2017 Results - Earnings Call TranscriptTeleflex (TFX) Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 2 at 3:40 PM
Vascular Solutions (VASC) & Myriad Genetics (MYGN) Critical SurveyVascular Solutions (VASC) & Myriad Genetics (MYGN) Critical Survey
www.americanbankingnews.com - September 9 at 2:12 AM
Analyzing VAREX IMAGING (VREX) and Vascular Solutions (VASC)Analyzing VAREX IMAGING (VREX) and Vascular Solutions (VASC)
www.americanbankingnews.com - September 5 at 10:22 AM
Head-To-Head Analysis: Vascular Solutions (VASC) vs. Myriad Genetics (MYGN)Head-To-Head Analysis: Vascular Solutions (VASC) vs. Myriad Genetics (MYGN)
www.americanbankingnews.com - September 3 at 4:02 AM
Financial Comparison: Myriad Genetics (MYGN) vs. Vascular Solutions (VASC)Financial Comparison: Myriad Genetics (MYGN) vs. Vascular Solutions (VASC)
www.americanbankingnews.com - August 30 at 4:26 PM
Reviewing Vascular Solutions (VASC) & Myriad Genetics (MYGN)Reviewing Vascular Solutions (VASC) & Myriad Genetics (MYGN)
www.americanbankingnews.com - August 29 at 8:06 PM
Comparing Vascular Solutions (VASC) and Cepheid (CPHD)Comparing Vascular Solutions (VASC) and Cepheid (CPHD)
www.americanbankingnews.com - August 27 at 12:28 AM
Head-To-Head Comparison: Vascular Solutions (VASC) and Varex Imaging (VREX)Head-To-Head Comparison: Vascular Solutions (VASC) and Varex Imaging (VREX)
www.americanbankingnews.com - August 25 at 4:30 PM
Financial Analysis: Varex Imaging (VREX) & Vascular Solutions (VASC)Financial Analysis: Varex Imaging (VREX) & Vascular Solutions (VASC)
www.americanbankingnews.com - August 18 at 6:14 PM
Financial Contrast: Cepheid (CPHD) & Vascular Solutions (NASDAQ:VASC)Financial Contrast: Cepheid (CPHD) & Vascular Solutions (NASDAQ:VASC)
www.americanbankingnews.com - August 10 at 3:02 PM
Teleflex (TFX) Q2 2017 Results - Earnings Call TranscriptTeleflex (TFX) Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 4 at 9:37 AM
Vascular Solutions (VASC) versus Cepheid (CPHD) Head-To-Head ContrastVascular Solutions (VASC) versus Cepheid (CPHD) Head-To-Head Contrast
www.americanbankingnews.com - August 4 at 7:42 AM
Head to Head Survey: Vascular Solutions (VASC) & Sequenom (SQNM)Head to Head Survey: Vascular Solutions (VASC) & Sequenom (SQNM)
www.americanbankingnews.com - July 13 at 8:30 PM
Head to Head Survey: Oxford Immunotec Global PLC (OXFD) & Vascular Solutions (VASC)Head to Head Survey: Oxford Immunotec Global PLC (OXFD) & Vascular Solutions (VASC)
www.americanbankingnews.com - July 1 at 8:12 AM
BRIEF-Teleflexs (TFX) Vascular Solutions issues recall of venture cathetersBRIEF-Teleflex's (TFX) Vascular Solutions issues recall of venture catheters
www.reuters.com - June 22 at 7:31 PM
Teleflex’s (TFX) Vascular Solutions, Inc. Issues Recall of Venture ® CathetersTeleflex’s (TFX) Vascular Solutions, Inc. Issues Recall of Venture ® Catheters
www.businesswire.com - June 22 at 7:31 PM
Teleflex to Introduce Arrow AC3 Optimus at EuroPCR, ParisTeleflex to Introduce Arrow AC3 Optimus at EuroPCR, Paris
www.zacks.com - May 16 at 8:24 AM
Sunshine Heart Hires Gordon Weber as Vice President, General CounselSunshine Heart Hires Gordon Weber as Vice President, General Counsel
globenewswire.com - May 16 at 8:24 AM
Teleflex Lifts 2017 Profit ViewTeleflex Lifts 2017 Profit View
www.nasdaq.com - May 4 at 9:49 AM
1:01 pm Index Changes Reminder: Progenics Pharmaceuticals (<a href="/q?s=pgnx" name="pgnx">PGNX</a>) replaced Calamos Asset (<a href="/q?s=clms" name="clms">CLMS</a>) in the S&P SmallCap 600 this morning; and Shutterfly (<a href="/q?s=sfly"1:01 pm Index Changes Reminder: Progenics Pharmaceuticals (PGNX) replaced Calamos Asset (CLMS) in the S&P SmallCap 600 this morning; and Shutterfly (
us.rd.yahoo.com - February 23 at 3:06 AM
VASCULAR SOLUTIONS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of AcquisitionVASCULAR SOLUTIONS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisition
biz.yahoo.com - February 22 at 10:46 AM
VASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, FinanciVASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, Financi
biz.yahoo.com - February 17 at 5:57 AM
Vascular Solutions CEO Howard Root stands to receive $8M in sale of companyVascular Solutions CEO Howard Root stands to receive $8M in sale of company
www.bizjournals.com - January 19 at 4:18 PM
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Shareholders To Contact The Firm For Additional ...INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Shareholders To Contact The Firm For Additional ...
www.businesswire.com - December 18 at 4:04 AM
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Investors To Contact The Firm For Additional ...SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Investors To Contact The Firm For Additional ...
www.businesswire.com - December 14 at 8:19 AM
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Vascular Solutions, Inc. to Teleflex Incorporated for $24 Per Share is Fair to ...INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Vascular Solutions, Inc. to Teleflex Incorporated for $24 Per Share is Fair to ...
www.businesswire.com - December 7 at 9:13 PM
Company News for December 05, 2016Company News for December 05, 2016
us.rd.yahoo.com - December 5 at 3:56 PM
Ryan & Maniskas, LLP Announces Investigation of Vascular Solutions, Inc.Ryan & Maniskas, LLP Announces Investigation of Vascular Solutions, Inc.
us.rd.yahoo.com - December 5 at 3:56 PM
VASCULAR SOLUTIONS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Teleflex IncorporatedVASCULAR SOLUTIONS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Teleflex Incorporated
us.rd.yahoo.com - December 5 at 3:56 PM
Medical device maker Teleflex to buy Vascular Solutions for $1 billionMedical device maker Teleflex to buy Vascular Solutions for $1 billion
www.foxnews.com - December 3 at 9:37 AM

SEC Filings

Vascular Solutions (NASDAQ:VASC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Vascular Solutions (NASDAQ:VASC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Vascular Solutions (NASDAQ VASC) Stock Chart for Sunday, February, 18, 2018

Loading chart…

This page was last updated on 2/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.